Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Anti-CD3 antibodies, anti-CD123 antibodies and bispecific antibodies specifically binding to CD3 and/or CD123

US Patent 10906978 · Granted Feb 2, 2021

Estimated economic value: $15,063,000

Assignee

Inventors

View full patent text on Google Patents →